TY - JOUR
T1 - Identification of the E3 ligase TRIM29 as a critical checkpoint regulator of NK cell functions
AU - Dou, Yaling
AU - Xing, Junji
AU - Kong, Gangcheng
AU - Wang, Guangchuan
AU - Lou, Xiaohua
AU - Xiao, Xiang
AU - Vivier, Eric
AU - Li, Xian C
AU - Zhang, Zhiqiang
N1 - Copyright © 2019 by The American Association of Immunologists, Inc.
PY - 2019/8/15
Y1 - 2019/8/15
N2 - NK cells play an important role in immune surveillance and protective immunity, mainly through rapid cytokine release and cytolytic activities. But how such responses are negatively regulated remains poorly defined. In this study, we demonstrated that the E3 ubiquitin ligase TRIM29 is a crucial regulator of NK cell functions. We found that TRIM29 was not expressed in resting NK cells, but was readily upregulated following activation, especially after IL-12 plus IL-18 stimulation. The levels of TRIM29 expression were inversely correlated with IFN-g production by NK cells, suggesting that TRIM29 inhibits NK cell functions. Indeed, deficiency of TRIM29, specifically in NK cells, resulted in an enhanced IFN-g production and consequently protected mice from murine CMV infection. Mechanistically, we showed that once induced in NK cells, TRIM29 ubiquitinates and degrades the TGF-b–activated kinase 1 binding protein 2 (TAB2), a key adaptor protein in IFN-g production by NK cells. These results identify TRIM29 as a negative regulator of NK cell functions and may have important clinical implications.
AB - NK cells play an important role in immune surveillance and protective immunity, mainly through rapid cytokine release and cytolytic activities. But how such responses are negatively regulated remains poorly defined. In this study, we demonstrated that the E3 ubiquitin ligase TRIM29 is a crucial regulator of NK cell functions. We found that TRIM29 was not expressed in resting NK cells, but was readily upregulated following activation, especially after IL-12 plus IL-18 stimulation. The levels of TRIM29 expression were inversely correlated with IFN-g production by NK cells, suggesting that TRIM29 inhibits NK cell functions. Indeed, deficiency of TRIM29, specifically in NK cells, resulted in an enhanced IFN-g production and consequently protected mice from murine CMV infection. Mechanistically, we showed that once induced in NK cells, TRIM29 ubiquitinates and degrades the TGF-b–activated kinase 1 binding protein 2 (TAB2), a key adaptor protein in IFN-g production by NK cells. These results identify TRIM29 as a negative regulator of NK cell functions and may have important clinical implications.
UR - http://www.scopus.com/inward/record.url?scp=85070384287&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85070384287&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1900171
DO - 10.4049/jimmunol.1900171
M3 - Article
C2 - 31270148
SN - 0022-1767
VL - 203
SP - 873
EP - 880
JO - Journal of immunology (Baltimore, Md. : 1950)
JF - Journal of immunology (Baltimore, Md. : 1950)
IS - 4
ER -